Mycobacterium tuberculosis Is Resistant to Isoniazid at a Slow Growth Rate by Single Nucleotide Polymorphisms in katG Codon Ser315

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug Targets

(2015) K. Mdluli et al.   Cold Spring Harbor Perspectives in Medicine

Latent Tuberculosis Infection: Myths, Models, and Molecular Mechanisms

(2014) N. K. Dutta et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

Whole Genome Sequencing of Mycobacterium tuberculosis Reveals Slow Growth and Low Mutation Rates during Latent Infections in Humans

(2014) Roberto Colangeli et al.   PLoS One

Metabolic aspects of bacterial persisters

(2014) Marcel Prax et al.   Frontiers in Cellular and Infection Microbiology

Evolution of Escherichia coli rifampicin resistance in an antibiotic-free environment during thermal stress

(2013) Alejandra Rodríguez-Verdugo et al.   BMC EVOLUTIONARY BIOLOGY

Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates

(2013) G. Brandis et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Dynamic Persistence of Antibiotic-Stressed Mycobacteria

(2013) Y. Wakamoto et al.   SCIENCE

The Posttranslocational Chaperone Lipoprotein PrsA Is Involved in both Glycopeptide and Oxacillin Resistance in Staphylococcus aureus

(2012) Ambre Jousselin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of the Mmr Efflux Pump in Drug Resistance in Mycobacterium tuberculosis

(2012) L. Rodrigues et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A screen for non-coding RNA in Mycobacterium tuberculosis reveals a cAMP-responsive RNA that is expressed during infection

(2012) Shaaretha Pelly et al.   GENE

Non-coding RNA and its potential role in Mycobacterium tuberculosis pathogenesis

(2012) Kristine Arnvig et al.   RNA Biology

Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex

(2011) Liliana Rodrigues et al.   INFECTION GENETICS AND EVOLUTION

Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection

(2011) Christopher B Ford et al.   NATURE GENETICS

Sequence-Based Analysis Uncovers an Abundance of Non-Coding RNA in the Total Transcriptome of Mycobacterium tuberculosis

(2011) Kristine B. Arnvig et al.   PLoS Pathogens

Mycobacterium tuberculosis Dihydrofolate Reductase Is Not a Target Relevant to the Antitubercular Activity of Isoniazid

(2010) F. Wang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis

(2010) J. E. M. de Steenwinkel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Multiple small RNAs identified in Mycobacterium bovis BCG are also expressed in Mycobacterium tuberculosis and Mycobacterium smegmatis

(2010) J. M. DiChiara et al.   NUCLEIC ACIDS RESEARCH

Enhanced heterogeneity of rpoB in Mycobacterium tuberculosis found at low pH

(2009) C. Jenkins et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance

(2009) Indra L. Bergval et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Identification of small RNAs inMycobacterium tuberculosis

(2009) Kristine B. Arnvig et al.   MOLECULAR MICROBIOLOGY

The Genetic Requirements for Fast and Slow Growth in Mycobacteria

(2009) Dany J. V. Beste et al.   PLoS One

The effect of oxidative stress on the mutation rate of Mycobacterium tuberculosis with impaired catalase/peroxidase function

(2008) D. M. O'Sullivan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY